LGT Capital Partners LTD. Has $74.95 Million Position in Stryker Corporation $SYK

LGT Capital Partners LTD. increased its holdings in Stryker Corporation (NYSE:SYK) by 3.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 213,252 shares of the medical technology company’s stock after purchasing an additional 7,483 shares during the quarter. Stryker accounts for about 3.7% of LGT Capital Partners LTD.’s holdings, making the stock its 8th biggest holding. LGT Capital Partners LTD.’s holdings in Stryker were worth $74,952,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of SYK. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker during the fourth quarter worth $26,000. United Financial Planning Group LLC purchased a new stake in shares of Stryker during the 3rd quarter valued at $27,000. Strive Asset Management LLC purchased a new stake in shares of Stryker during the 3rd quarter valued at $30,000. CGC Financial Services LLC purchased a new stake in shares of Stryker during the 4th quarter valued at $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new stake in shares of Stryker during the 3rd quarter valued at $34,000. Institutional investors own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. The Goldman Sachs Group reiterated a “neutral” rating and set a $361.00 price objective on shares of Stryker in a report on Friday, May 1st. Needham & Company LLC decreased their price objective on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a report on Friday, May 1st. UBS Group decreased their price objective on Stryker from $400.00 to $380.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Canaccord Genuity Group decreased their price objective on Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Citigroup decreased their price objective on Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a report on Tuesday, April 7th. Sixteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $395.33.

Insider Activity

In other news, Director Ronda E. Stryker sold 310,000 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the sale, the director directly owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. The trade was a 13.87% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Robert S. Fletcher sold 4,544 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president directly owned 10,582 shares in the company, valued at $3,247,298.34. This trade represents a 30.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 323,264 shares of company stock valued at $100,659,489 over the last ninety days. 4.60% of the stock is currently owned by insiders.

Stryker Price Performance

Shares of SYK opened at $301.75 on Tuesday. The firm has a market capitalization of $115.68 billion, a PE ratio of 34.92, a price-to-earnings-growth ratio of 1.93 and a beta of 0.78. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $404.87. The company’s fifty day moving average price is $317.81 and its 200-day moving average price is $345.36.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. Stryker’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the firm earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts predict that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.2%. Stryker’s payout ratio is 40.74%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.